Mental health services boosted by £150 million government funding

£150 million will be used to build 150 new facilities to support mental health urgent and emergency care services. Anyone experiencing a mental health emergency will benefit from more tailored emergency care and support in the community through specialised mental health ambulances, more crisis services and improved health-based places of...

R&D tax credits – Draft Guidance from HMRC

This Article was written by Medilink Midlands Patron, TBAT Innovation. HMRC R&D Communication Forum (RDCF) In December, HMRC issued their Draft Guidance notes, which give more detail than previously seen documents (in some areas) about the future changes to R&D tax claims. This guidance can be summarised as the following: ...

Introducing Dr. Lisa Page, Partner, Penningtons Manches Cooper

After completing a PhD in molecular microbiology and almost 15 years in the pharmaceutical industry including project managing Phase II and Phase III global clinical trials for pharmaceutical clients at IQVIA, I re-trained and qualified as an IP lawyer. My career change occurred after a conversation with an IP lawyer....

Potter Clarkson: The Innovation Game

Potter Clarkson's The Innovation Game podcast is back for episode 12 - 101 of Medical Device regulatory strategies – where to begin? In this episode patent attorney Richard Wells welcomes external guest Timothy Bubb from IMed Consultancy Ltd. They discuss all things Medical Devices - covering what exactly they are,...

Derby Based Medical Technology Manufacturer, Pennine Healthcare Celebrates Historic Anniversary

Pennine Healthcare, one of the UK’s leading, employee owned, medical device manufacturers is celebrating its 60th year of trading. To acknowledge the significant achievement, Pennine have launched a celebratory re-brand, with new logo that encapsulates the anniversary, and new tagline. Pennine will also be celebrating later in the year, with...

PANORAMIC clinical trial finds molnupiravir does not reduce COVID-19 hospitalisation/deaths in vaccinated people at high risk

Researchers have today released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 – the first treatment tested in the ongoing PANORAMIC trial. The Platform Adaptive trial of NOvel antiviRals for eArly treatMent of COVID-19 In the Community (PANORAMIC) was developed by Professor Sir Jonathan Van-Tam, Pro-Vice-Chancellor for the...

Intellomx Receives Coveted Approval in China

Simon Haworth, Director of Intellomx The Ministry of Science & Technology (MOST) in Beijing announced this week that UK drug-discovery AI company Intelligent OMICS has been granted approval for its Tuberculosis study in Wuhan, China. The study aims to validate both a panel of diagnostic biomarkers that predicts the presence...